Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Poly (ADP-ribose) Polymerase Inhibitors Have Comparable Efficacy with Platinum Chemotherapy in Patients with BRCA-positive Metastatic Castration-resistant Prostate Cancer. A Systematic Review and Meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Kói T, Ács N, Hegyi P, Hadaschik B, Nyirády P, Szarvas T. Fazekas T, et al. Eur Urol Oncol. 2023 Sep 16:S2588-9311(23)00174-8. doi: 10.1016/j.euo.2023.09.001. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37722977 Free article. Review.
High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma.
Széles Á, Kovács PT, Csizmarik A, Váradi M, Riesz P, Fazekas T, Váncsa S, Hegyi P, Oláh C, Tschirdewahn S, Darr C, Krafft U, Grünwald V, Hadaschik B, Horváth O, Nyirády P, Szarvas T. Széles Á, et al. Among authors: fazekas t. Biomedicines. 2022 Oct 13;10(10):2560. doi: 10.3390/biomedicines10102560. Biomedicines. 2022. PMID: 36289821 Free PMC article.
Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Széles Á, Fazekas T, Váncsa S, Váradi M, Kovács PT, Krafft U, Grünwald V, Hadaschik B, Csizmarik A, Hegyi P, Váradi A, Nyirády P, Szarvas T. Széles Á, et al. Among authors: fazekas t. Cancer Immunol Immunother. 2023 May;72(5):1061-1073. doi: 10.1007/s00262-022-03328-9. Epub 2022 Nov 16. Cancer Immunol Immunother. 2023. PMID: 36385210 Free PMC article. Review.
Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients-a systematic review and meta-analysis.
Fazekas T, Széles ÁD, Teutsch B, Csizmarik A, Vékony B, Váradi A, Kói T, Lang Z, Ács N, Kopa Z, Hegyi P, Hadaschik B, Grünwald V, Nyirády P, Szarvas T. Fazekas T, et al. Prostate Cancer Prostatic Dis. 2023 Dec;26(4):665-672. doi: 10.1038/s41391-022-00626-2. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509931 Free PMC article. Review.
Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study.
Váradi M, Horváth O, Módos O, Fazekas T, Grunewald CM, Niegisch G, Krafft U, Grünwald V, Hadaschik B, Olah C, Maráz A, Furka A, Szűcs M, Nyirády P, Szarvas T. Váradi M, et al. Among authors: fazekas t. Sci Rep. 2023 Oct 13;13(1):17378. doi: 10.1038/s41598-023-44103-9. Sci Rep. 2023. PMID: 37833455 Free PMC article.
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A, Yanagisawa T, Bekku K, Kardoust Parizi M, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Fazekas T, Miszczyk M, Miki J, Kimura T, Karakiewicz PI, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: fazekas t. Eur Urol Oncol. 2024 Jan 4:S2588-9311(23)00292-4. doi: 10.1016/j.euo.2023.12.005. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38182488 Free article. Review.
A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer.
Tsuboi I, Matsukawa A, Kardoust Parizi M, Klemm J, Mancon S, Chiujdea S, Fazekas T, Miszczyk M, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Karakiewicz P, Wada K, Rouprêt M, Araki M, Shariat SF. Tsuboi I, et al. Among authors: fazekas t. Eur Urol Oncol. 2024 Apr 3:S2588-9311(24)00083-X. doi: 10.1016/j.euo.2024.03.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38575408 Free article. Review.
Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis.
Fazekas T, Shim SR, Basile G, Baboudjian M, Kói T, Przydacz M, Abufaraj M, Ploussard G, Kasivisvanathan V, Rivas JG, Gandaglia G, Szarvas T, Schoots IG, van den Bergh RCN, Leapman MS, Nyirády P, Shariat SF, Rajwa P. Fazekas T, et al. JAMA Oncol. 2024 Apr 5:e240734. doi: 10.1001/jamaoncol.2024.0734. Online ahead of print. JAMA Oncol. 2024. PMID: 38576242
167 results